Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate in Pediatric Asthma and Bronchiolitis
NCT06955559Phase 3Not yet recruiting
- Sponsor
- Assiut University
- Start
- May 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
01
Overview
Phase 3 trial of magnesium sulfate in asthma and bronchiolitis, sponsored by Assiut University. Primary endpoint: Safety of intravenous magnesium sulfate. Planned start May 2025; status: not yet recruiting.
02
Drugs
magnesium sulfate
03
Conditions
asthmabronchiolitis
Beyond the preview
Go deeper on NCT06955559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06955559.